Edesa Biotech Enrolls More Than 525 COVID-19 Patients Ahead of Schedule

Delta variant contributes to rapid enrollment amid growing scientific rationale for targeting Toll-like Receptor 4 (TLR4)Blinded interim analysis from Phase 2/3 study expected in current quarterTORONTO, ON / ACCESSWIRE / August 26, 2021 / Edesa …